Internal Medicine · Cincinnati, OH
NPI
1841213667
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1577 Goodman Ave Ste A
Cincinnati, OH, 45224
Phone (513) 403-3762
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
795 services
Medicare patients, 2024
89
Average age 70
Drug cost, 2024
$1.5M
15,450 prescriptions
Company payments, 2025
$1,475
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Waymon L Wallace was code 99214 (office e&m - established), 151 times for 65 patients. In total Waymon L Wallace billed 795 services in 36 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 151 | 65 | $80.57 | $12K |
| 99213 Office E&M - Established | Office | 80 | 52 | $42.05 | $3,364 |
| 82962 Clinical Chemistry | Office | 55 | 20 | $3.21 | $177 |
| 93000 Electrocardiogram | Office | 55 | 51 | $7.72 | $425 |
| 82043 Clinical Chemistry | Office | 52 | 19 | $5.66 | $294 |
| 83036 Blood Count | Office | 51 | 20 | $9.52 | $486 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 49 | 49 | $121.76 | $5,966 |
| 81002 Clinical Chemistry | Office | 44 | 43 | $3.41 | $150 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 31 | 31 | $16.60 | $515 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 25 | 15 | $23.90 | $598 |
| 99497 Care Management/Coordination | Office | 24 | 24 | $25.78 | $619 |
By year: 2022 $23K for 492 services; 2023 $23K for 1,364 services; 2024 $31K for 795 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 55 | 20 | $3.21 | $177 |
| 82043 Clinical Chemistry | 52 | 19 | $5.66 | $294 |
| 83036 Blood Count | 51 | 20 | $9.52 | $486 |
| 81002 Clinical Chemistry | 44 | 43 | $3.41 | $150 |
Medicare prescription drug claims, 2024
In 2024, the drug Waymon L Wallace prescribed most often to Medicare patients was Atorvastatin Calcium, with 931 prescriptions and refills. In total Waymon L Wallace wrote 15,450 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 931 | 1,265 | 135 | $18K |
| Amlodipine Besylate Generic | 611 | 852 | 98 | $7,204 |
| Gabapentin Generic | 384 | 457 | 64 | $8,466 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 377 | 377 | 48 | $16K |
| Furosemide Generic | 370 | 463 | 68 | $3,492 |
| Sertraline Hcl Generic | 311 | 327 | 39 | $4,942 |
| Omeprazole Generic | 310 | 482 | 55 | $3,324 |
| Levothyroxine Sodium Generic | 309 | 431 | 52 | $3,511 |
| Potassium Chloride Generic | 297 | 367 | 44 | $7,826 |
| Lisinopril Generic | 292 | 427 | 48 | $2,499 |
| Metoprolol Tartrate Generic | 281 | 329 | 42 | $3,491 |
| Metformin Hcl Generic | 267 | 414 | 46 | $2,906 |
| Tamsulosin Hcl Generic | 244 | 334 | 38 | $4,656 |
| Eliquis Apixaban | 243 | 271 | 39 | $158K |
| Pantoprazole Sodium Generic | 240 | 316 | 40 | $5,765 |
Brand drugs: 2,285 claims; generic drugs: 13,095 claims; opioid claims: 1,033.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Waymon L Wallace $1,475 ($1,475 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $261.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $261 |
| GlaxoSmithKline, LLC. GSK | 11 | $188 |
| Pfizer Inc. PFE | 12 | $162 |
| Lilly USA, LLC LLY | 10 | $157 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $94.47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90.14 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $83.22 |
| Lundbeck LLC | 4 | $74.17 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $58.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.